This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
AMN or ICLR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMN vs. ICLR: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: Verint Systems, Integer, AMN Healthcare Services, Xilinx and United States Cellular
by Zacks Equity Research
Zacks.com featured highlights include: Verint Systems, Integer, AMN Healthcare Services, Xilinx and United States Cellular
5 Stocks Trading Near 52-Week High with More Room to Run
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.
Teladoc (TDOC) Surges 64% in a Year: Can the Rally Continue?
by Zacks Equity Research
Teladoc (TDOC) is poised to grow on accelerating demand for its telehealth services.
Express Scripts (ESRX) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Express Scripts (ESRX) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AMN vs. ICLR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. ICLR: Which Stock Is the Better Value Option?
AMN Healthcare Services (AMN) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in AMN Healthcare Services, Inc. (AMN).
AMN vs. ICLR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. ICLR: Which Stock Is the Better Value Option?
BioTelemetry (BEAT) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
BioTelemetry (BEAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AMN Healthcare Services (AMN) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 9.09% and 0.08%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
AMN Healthcare Services (AMN) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for September 19th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
AMN Healthcare Services (AMN) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 5.06% and 4.36%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for June 15th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for June 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Unemployment Falls to Near 18-Year Low: 6 Winning Picks
by Swarup Gupta
Professional and business services led job gains, followed by healthcare and manufacturing.
AMN Healthcare Services (AMN) Enters Oversold Territory
by Zacks Equity Research
AMN Healthcare Services, Inc. (AMN) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Top 5 Stocks With Impressive Net Profit Margin
by Zacks Equity Research
Net profit margin can turn out to be an accurate point of reference to gauge the potential of a company's operations and cost-control measures.
5 Spectacular Earnings Charts
by Tracey Ryniec
Their shares are breaking out to new highs and they have excellent earnings surprise track records. What more could an investor want?
5 Stocks Near 52-Week High: Will These Scale Higher?
by Zacks Equity Research
These stocks have passed through a screen we ran to find those that are trading near their 52-week high levels and still have plenty of upside left.
Zacks.com highlights: Willdan Group, AMN Healthcare Services, Harsco, SP Plus and Lakeland Industries
by Zacks Equity Research
Zacks.com highlights: Willdan Group, AMN Healthcare Services, Harsco, SP Plus and Lakeland Industries
5 Stocks With a Handsome Net Profit Margin
by Zacks Equity Research
Net profit margin can turn out to be a potent point of reference to gauge the strength in a company operations and cost-control measures.
Zacks.com featured highlights include: Archer Daniels, AMN, Fluor, Fortinet and National General
by Zacks Equity Research
Zacks.com featured highlights include: Archer Daniels, AMN, Fluor, Fortinet and National General